-- 山東新華医薬(香港証券取引所:0719、上海証券取引所:000756)は、2026年第1四半期の帰属利益が前年同期の1億1210万元から25%減の8390万元となったことを、火曜日に香港証券取引所に提出した書類で明らかにした。 1株当たり利益は、前年同期の0.15元から0.12元に減少した。 同社の営業収益は、前年同期の24億3000万元から0.3%減の24億2000万元となった。
Related Articles
April Dallas Fed Service Sector Index -9.9 vs. -12 Expected, Prior -13.3 Reading
Update: UAE to Leave OPEC From May 1
(Updates with official statement and analyst comments throughout the story.)The UAE will withdraw from the Organization of the Petroleum Exporting Countries and its allies effective May 1, the country's Energy Minister Suhail Al Mazroui confirmed on social media Tuesday."The UAE's decision to exit from OPEC reflects a policy-driven evolution aligned with long-term market fundamentals," Al Mazroui posted on X.The energy minister told Reuters earlier that the government did not consult any other country before making the decision to leave the cartel. He said this decision will give the UAE the flexibility to make changes to production, storage and shipping energy products.The UAE joined OPEC in 1967 and as a producer of significant volumes, its membership of the group carried weight in its setting of production targets and ultimately global prices.One analyst noted that the veteran member is likely seeking freedom from output limitations to strongly raise output.OPEC is heavily influential over global oil prices through a monthly meeting in which many of the world's largest producers agree on production levels for the weeks ahead.Sparta energy analyst Phil Crosby said in written comments tothat the country's exit was not entirely surprising and had been "on the cards" for some time."They'll want to produce closer to what their capacity is longer term, which will put some pressure on oil, but having already lost 1 billion barrels of supply from the war, this won't be a huge headache for a while," Crosby said.He added that they can probably sustainably produce 4.5-4.8 million barrels per day once Hormuz opens, noting that the country was allowed 3.4 mmb/d under OPEC quotas.has reached out to other members of OPEC.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kinder Morgan
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price remains $36, based on a combination of our relative valuation and DCF models. On a relative basis, we apply an 11x multiple of enterprise value to projected '27 EBITDA, slightly above KMI's historical forward average. We think a slight premium is reasonable in light of growing demand for natural gas, helped by the twin secular drivers of LNG exports and data centers, and this multiple yields a value of $33 per share. Meanwhile, our DCF model, using free cash flow growth of 7.8% per year for 10 years and terminal growth of 2.5%, discounted at a WACC of 6.2%, yields intrinsic value of $39 per share. We raise our '26 EPS estimate by $0.12 to $1.48, but cut '27's by $0.03 to $1.47. Although the EIA's estimates of natural gas pricing have come slightly off the boil, we still think pricing in the high $3 per MMBtu range (which is what we see for 2026-2027) is sufficient to encourage incremental demand for gas midstream services, which KMI provides.